Position
EntryPoint Capital, LLC in Compass Therapeutics, Inc.
Back to the book · All holders of CMPX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.05K$5.37 → $5.29
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 13.2K | $70.7K | — | — | — | 0.0% |
| Q1 2026 | 29.3K | $154.8K | $5.29 | −$1.05K | $85.2K | 0.0% |